191 related articles for article (PubMed ID: 6421041)
1. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers.
Chihara K; Iwasaki J; Minamitani N; Kaji H; Kodama H; Fujita T; Shirataki K; Tamaki N; Matsumoto S
Acta Endocrinol (Copenh); 1984 Jan; 105(1):6-13. PubMed ID: 6421041
[TBL] [Abstract][Full Text] [Related]
2. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
3. Effect of vasoactive intestinal polypeptide on growth hormone secretion in perifused acromegalic pituitary adenoma tissues.
Chihara K; Iwasaki J; Minamitani N; Kaji H; Matsukura S; Tamaki N; Matsumoto S; Fujita T
J Clin Endocrinol Metab; 1982 Apr; 54(4):773-9. PubMed ID: 6120948
[TBL] [Abstract][Full Text] [Related]
4. [A study on the prolactin releasing mechanism using an in vitro perfusion system with a cell column of cultured rat anterior pituitary cells].
Kageyama J
Nihon Naibunpi Gakkai Zasshi; 1984 Oct; 60(10):1243-54. PubMed ID: 6440813
[TBL] [Abstract][Full Text] [Related]
5. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
[TBL] [Abstract][Full Text] [Related]
6. [The properties of prolactin secretion in patients with prolactin secreting pituitary adenomas].
Sato S
Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):947-60. PubMed ID: 3123284
[TBL] [Abstract][Full Text] [Related]
7. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.
Le Dafniet M; Lefebvre P; Barret A; Mechain C; Feinstein MC; Brandi AM; Peillon F
J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264
[TBL] [Abstract][Full Text] [Related]
8. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
9. D2 Dopamine receptor subtype mediates the inhibitory effect of dopamine on TRH-induced prolactin release from the bullfrog pituitary.
Nakano M; Minagawa A; Hasunuma I; Okada R; Tonon MC; Vaudry H; Yamamoto K; Kikuyama S; Machida T; Kobayashi T
Gen Comp Endocrinol; 2010 Sep; 168(2):287-92. PubMed ID: 20553721
[TBL] [Abstract][Full Text] [Related]
10. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma.
Hanew K; Utsumi A; Sugawara A; Shimizu Y; Yoshinaga K
Acta Endocrinol (Copenh); 1991 May; 124(5):545-52. PubMed ID: 1903012
[TBL] [Abstract][Full Text] [Related]
11. Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH.
Bevan JS; Burke CW
Clin Endocrinol (Oxf); 1989 Jun; 30(6):667-80. PubMed ID: 2512041
[TBL] [Abstract][Full Text] [Related]
12. Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions.
Jaquet P; Gunz G; Grisoli F
Horm Res; 1985; 22(3):153-63. PubMed ID: 3932176
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of prolactin secretion from diethylstilbestrol-induced rat prolactinoma tissue in vitro.
Maas DL; Martinson DR; Erdmann MD; Wahle JS; Hagen TC
Proc Soc Exp Biol Med; 1995 Nov; 210(2):150-5. PubMed ID: 7568285
[TBL] [Abstract][Full Text] [Related]
14. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
[TBL] [Abstract][Full Text] [Related]
15. Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells.
Ben-Shlomo A; Miklovsky I; Ren SG; Yong WH; Heaney AP; Culler MD; Melmed S
J Clin Endocrinol Metab; 2003 Feb; 88(2):858-63. PubMed ID: 12574225
[TBL] [Abstract][Full Text] [Related]
16. Altered responsiveness to hypophysiotrophic hormones of perifused rat pituitary tumours.
Carlson HE; Mariz IK; Briggs JE; Daughaday WH
Acta Endocrinol (Copenh); 1977 Mar; 84(3):512-22. PubMed ID: 190840
[TBL] [Abstract][Full Text] [Related]
17. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
18. The effect of dopamine on thyrotropin-releasing hormone-induced prolactin secretion in vitro.
Fagin KD; Neill JD
Endocrinology; 1981 Dec; 109(6):1835-40. PubMed ID: 6796383
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants.
Hashizume T; Onodera Y; Shida R; Isobe E; Suzuki S; Sawai K; Kasuya E; Nagy GM
Domest Anim Endocrinol; 2009 Feb; 36(2):99-104. PubMed ID: 19070987
[TBL] [Abstract][Full Text] [Related]
20. Presence of high affinity dopamine receptors in estrone-induced, prolactin-secreting rat pituitary adenomas: a model for human prolactinomas.
Eljarmak D; Marchisio AM; Lis M; Collu R
Horm Res; 1985; 21(2):107-16. PubMed ID: 3920132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
